Evidence map›Paper›PMID 25153994›Full record

ArticlePloS one2014

Tau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer's disease.

Paul D Wes, Amy Easton, John Corradi, Donna M Barten, Nino Devidze, Lynn B DeCarr, Amy Truong, Aiqing He, Nestor X Barrezueta, Craig Polson and 10 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 76 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Paul D WesDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Amy EastonDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
John CorradiDepartment of Applied Genomics, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Donna M BartenDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Nino DevidzeDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Lynn B DeCarrDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Amy TruongDepartment of Applied Genomics, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Aiqing HeDepartment of Applied Genomics, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Nestor X BarrezuetaDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Craig PolsonDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Clotilde BourinDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Marianne E FlynnDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Stefanie KeenanDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Regina LidgeDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Jere MeredithDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Joanne NataleDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Sethu SankaranarayananDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Greg W CadelinaDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Charlie F AlbrightDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Angela M CacaceDepartment of Neuroscience, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America.
Bristol-Myers Squibb (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Filamentous inclusions of the microtubule-associated protein, tau, define a variety of neurodegenerative diseases known as tauopathies, including Alzheimer's disease (AD). To better understand the role of tau-mediated effects on pathophysiology and global central nervous system function, we extensively characterized gene expression, pathology and behavior of the rTg4510 mouse model, which overexpresses a mutant form of human tau that causes Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). We found that the most predominantly altered gene expression pathways in rTg4510 mice were in inflammatory processes. These results closely matched the causal immune function and microglial gene-regulatory network recently identified in AD. We identified additional gene expression changes by laser microdissecting specific regions of the hippocampus, which highlighted alterations in neuronal network activity. Expression of inflammatory genes and markers of neuronal activity changed as a function of age in rTg4510 mice and coincided with behavioral deficits. Inflammatory changes were tau-dependent, as they were reversed by suppression of the tau transgene. Our results suggest that the alterations in microglial phenotypes that appear to contribute to the pathogenesis of Alzheimer's disease may be driven by tau dysfunction, in addition to the direct effects of beta-amyloid.

Indexed as

Alzheimer DiseaseAnimalsChromosomes, Human, Pair 17Disease Models, AnimalFemaleFrontotemporal DementiaGene ExpressionGene Regulatory NetworksHippocampusHumansInflammationMiceMicrogliaMicrotubule-Associated ProteinsNeurodegenerative DiseasesNeuronsMicrotubule-Associated Proteinstau Proteins

Identifiers

PMID25153994
PMCPMC4143352
OpenAlexW1986832216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.